EMED CORP has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are PILOGICS L P, JOLLY CLAUDE and ROGERS SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Syringes | |
#3 | Implantable devices | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds | |
#6 | Medical preparations | |
#7 | Microbiology | |
#8 | Winches |
# | Name | Total Patents |
---|---|---|
#1 | Walsh Robert G | 10 |
#2 | Shapland J Edward | 8 |
#3 | Conrad-Vlasak Deena | 7 |
#4 | Walsh Robert | 4 |
#5 | Vanden Hoek John C | 4 |
#6 | Fowler Jan Ellen | 3 |
#7 | Pertile Terence | 3 |
#8 | Dockter John | 3 |
#9 | Vanden Hoek John | 2 |
#10 | Shapland Edward | 2 |
Publication | Filing date | Title |
---|---|---|
AU1620300A | Electrically mediated angiogenesis | |
WO9936563A1 | Electrically mediated cellular expression | |
WO9904850A1 | Needle for iontophoretic delivery of agent | |
WO9904851A1 | Iontophoretic delivery of an agent into cardiac tissue | |
EP0959933A1 | Combined coronary stent deployment and local delivery of an agent |